Cross-Platform Comparison of Four Leading Technologies for Detecting EGFR Mutations in Circulating Tumor DNA from Non-Small Cell Lung Carcinoma Patient Plasma

Analysis of circulating tumor DNA (ctDNA) is emerging as a powerful tool for guiding targeted therapy and monitoring tumor evolution in patients with non-small cell lung cancer (NSCLC), especially when representative tissue biopsies are not available. Here, we have compared the ability of four leadi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ting, Kang, Xiaozheng, You, Xiaofang, Dai, Liang, Tian, Dequan, Yan, Wanpu, Yang, Yongbo, Xiong, Hongchao, Liang, Zhen, Zhao, Grace Q., Lin, Shengrong, Chen, Ke-Neng, Xu, Guobing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436504/
https://www.ncbi.nlm.nih.gov/pubmed/28529628
http://dx.doi.org/10.7150/thno.16558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436504/
https://www.ncbi.nlm.nih.gov/pubmed/28529628
http://dx.doi.org/10.7150/thno.16558

Ejemplares similares